Loading...
Loading...
Among the 6 tracked institutional investors we monitor, TBPH (THERAVANCE BIOPHARMA INC) is held with a combined value of $141.07M across 8,330,039 shares. The largest holder is BlackRock, Inc. with a position worth $69.73M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$141.07M
Total Shares Held
8,330,039
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $69.73M | 0.00% | +6.1% |
| 2 | VANGUARD GROUP INC | $44.29M | 0.00% | New |
| 3 | STATE STREET CORP | $21.06M | 0.00% | +17.7% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $2.08M | 0.00% | New |
| 5 | FMR LLC | $2.00M | 0.00% | +2167.9% |
| 6 | CITADEL ADVISORS LLC | $1.92M | 0.00% | -49.9% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of TBPH with a position worth $69.73M, representing 0.00% of their portfolio. In total, 6 institutional investors hold TBPH with a combined value of $141.07M.
In the most recent quarter, 2 funds opened a new position in TBPH. Additionally, 3 increased their holdings and 1 reduced their positions.
Institutional investors hold $141.07M worth of TBPH stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $69.73M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TBPH, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TBPH positions.